TMEM165 Gene Glycosylation Disorder Type 2K Genetic Test sale cost 4400 AED
ALG3 Gene Glycosylation Disorder Type 1D Genetic Test sale cost 4400 AED ALG3 Gene Glycosylation Disorder Type 1D Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
GPI Gene Hemolytic Anemia Nonspherocytic Due to Glucose Phosphate Isomerase Deficiency Genetic Test sale cost 4400 AED GPI Gene Hemolytic Anemia Nonspherocytic Due to Glucose Phosphate Isomerase Deficiency Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

TMEM165 Gene Glycosylation Disorder Type 2K Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TMEM165 Gene Glycosylation Disorder Type 2K Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TMEM165 gene. These mutations are associated with Congenital Disorders of Glycosylation (CDG), specifically Type 2K, a rare genetic condition that affects the normal process of glycosylation – the addition of sugar molecules to proteins and lipids, which is crucial for their proper function.

This disorder presents a spectrum of clinical manifestations, ranging from mild to severe, including developmental delay, neurological issues, and abnormalities in liver function, among others. Early and accurate diagnosis through genetic testing can be vital for the management and treatment of the condition, offering insights into potential therapies and interventions.

The test is priced at 4400 AED and involves analyzing the patient’s DNA sample to look for specific genetic alterations in the TMEM165 gene that are indicative of Type 2K CDG. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test adheres to the highest standards of accuracy and reliability, ensuring that patients receive precise and actionable genetic information.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TMEM165 Gene Glycosylation disorder type 2K Genetic Test

Welcome to DNA Labs UAE, where we offer the TMEM165 Gene Glycosylation disorder type 2K Genetic Test. This test helps diagnose Congenital Disorder of Glycosylation Type 2K (CDG2K), a rare genetic disorder affecting the glycosylation process in the body.

Test Details

The TMEM165 gene is associated with CDG2K, a genetic disorder that affects the attachment of sugar molecules to proteins and lipids in the body. Our NGS (Next-Generation Sequencing) technology allows us to analyze multiple genes simultaneously, including the TMEM165 gene, to identify any genetic variations or mutations causing the glycosylation disorder.

Test Components and Price

The TMEM165 Gene Glycosylation disorder type 2K Genetic Test is priced at 4400.0 AED. The test requires a blood or extracted DNA sample, or one drop of blood on an FTA card.

Report Delivery

Once the sample is collected, the report will be delivered within 3 to 4 weeks.

Test Type and Method

The TMEM165 Gene Glycosylation disorder type 2K Genetic Test falls under the category of Metabolic Disorders. We utilize NGS technology to analyze the DNA sequence and identify any genetic variations or mutations in the TMEM165 gene.

Referring Doctor and Test Department

The referring doctor for this test is a General Physician. The test is conducted in our Genetics department.

Pre Test Information

Prior to the TMEM165 Gene Glycosylation disorder type 2K Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected by Glycosylation disorder type 2K.

Understanding CDG2K

CDG2K is a rare genetic disorder that affects the glycosylation process. The TMEM165 gene provides instructions for producing a protein involved in sugar molecule transport within cells. Mutations in this gene can cause the glycosylation disorder, leading to various symptoms and complications.

NGS Genetic Testing Process

The NGS genetic test for TMEM165 gene mutations involves collecting a DNA sample, usually through blood or saliva. The DNA is then sequenced to identify any variations or mutations in the gene. These results help healthcare professionals understand the underlying cause of the glycosylation disorder and guide treatment and management strategies for individuals with CDG2K.

At DNA Labs UAE, we are dedicated to providing accurate and reliable genetic testing services. If you suspect CDG2K or have any concerns about glycosylation disorders, consult with our expert team and get the TMEM165 Gene Glycosylation disorder type 2K Genetic Test today.

Test Name TMEM165 Gene Glycosylation disorder type 2K Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TMEM165 Gene Glycosylation disorder type 2K NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 2K
Test Details

The TMEM165 gene is associated with a glycosylation disorder called Congenital Disorder of Glycosylation Type 2K (CDG2K). CDG2K is a rare genetic disorder that affects the glycosylation process, which is the attachment of sugar molecules to proteins and lipids in the body. This gene is responsible for providing instructions for the production of a protein that is involved in the transport of sugar molecules within cells.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze a person’s DNA sequence. It allows for the simultaneous analysis of multiple genes, including the TMEM165 gene, to identify any genetic variations or mutations that may be causing the glycosylation disorder. This type of genetic testing can help confirm a diagnosis of CDG2K and provide information about the specific genetic variant causing the disorder.

The NGS genetic test for TMEM165 gene mutations typically involves collecting a DNA sample, usually through a blood or saliva sample, and sequencing the DNA to identify any variations or mutations in the gene. The results of the test can help healthcare professionals better understand the underlying cause of the glycosylation disorder and may inform treatment options and management strategies for individuals with CDG2K.

SKU: TEST-2398 Category:

Related products